ZELTIQ® Aesthetics, Inc. (Nasdaq: ZLTQ), is a medical device company that makes the CoolSculpting® system, which is designed to target and eliminate stubborn fat that may not respond to diet or exercise.

The technology is based on the scientific principle of Cryolipolysis®, the elimination of fat cells through cold without affecting the overlying skin and surrounding tissue. The CoolSculpting system has been clinically proven safe and effective in more than 60 published papers and over 3 million procedures have been performed worldwide.

Zeltiq was founded in 2005 and became a publicly-traded company in 2011. Zeltiq is based in Pleasanton, California with a worldwide sales force. We also have offices in:
Dublin, California
Livermore, California
Reston, Virginia
Redhill, U.K.
Galway, Ireland

If you are interested to read more about ZELTIQ or our financial information, please see www.zeltiq.com.